Rat liver-mediated metabolism of hydroxyurea to nitric oxide

Free Radical Biology and Medicine

Volumn 40, Issue 9, 2006, Pages 1675-1681

  Huang, Jinming ^a   Yakubu, Mamudu ^b   Kim Shapiro, Daniel B ^a   King, S Bruce ^a  

^a WAKE FOREST UNIVERSITY   (United States)

^b ELIZABETH CITY STATE UNIVERSITY   (United States)

Author keywords

Catalase; Free radical; Hydroxyurea; Liver; Metabolism; Nitric oxide; Nitroxyl

Indexed keywords

HYDROXYUREA; NITRIC OXIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; GAS CHROMATOGRAPHY; HYDROLYSIS; LIVER METABOLISM; MASS SPECTROMETRY; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT;

ANIMALS; CATALASE; CHEMILUMINESCENT MEASUREMENTS; ELECTRON SPIN RESONANCE SPECTROSCOPY; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HYDROXYUREA; LIVER; MICROSOMES, LIVER; NITRIC OXIDE; RATS;

ANIMALIA;

EID: 33646058537     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2006.01.002     Document Type: Article

References (29)

1. Steinberg M.H., Barton F., Castro O., Pegelow C.H., Ballas S.K., Kutlar A., Orringer E., Bellevue R., Olivieri N., Eckman J., Varmo M., Ramirez G., Adler B., Smith W., Carlos T., Ataga K., DeCastro L., Bigelow C., Saunthararajah Y., Telfer M., Vichinsky E., Claster S., Shurin S., Bridges K., Waclawiw M., Bonds D., and Terrin M. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA 289 (2003) 1645-1651
2. Charache S., Terrin M.L., Moore R.D., Dover G.J., Barton F.B., Eckert S.V., McMahon R.P., Bonds D.R., and The Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N. Engl. J. Med. 332 (1995) 1317-1322
3. Charache S., Barton F.B., Moore R.D., Terrin M.L., Steinberg M.H., Dover G.J., Ballas S.K., McMahon P., Castro O., Orringer E.P., and The Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Hydroxyurea and sickle cell anemia. Medicine 75 (1996) 300-326
4. Halsey C., and Roberts I.A.G. The role of hydroxyurea in sickle cell disease. Br. J. Haematol. 120 (2003) 177-186
5. King S.B. The nitric oxide producing reactions of hydroxyurea. Curr. Med. Chem. 10 (2003) 437-452
6. Gladwin M.T., Shelhamer J.H., Ognibene F.P., Pease-Fye M.E., Nichols J.S., Link B., Patel D.B., Jankowski M.A., Pannell L.K., Schechter A.N., and Rodgers G.P. Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease. Br. J. Haematol. 116 (2002) 436-444
7. Nahavandi M., Tavakkoli F., Wyche M.Q., Perlin E., Winter W.P., and Castro O. Nitric oxide and cyclic GMP levels in sickle cell patients receiving hydroxyurea. Br. J. Haematol. 119 (2002) 855-857
8. Lockamy V.L., Huang J., Shields H., Ballas S.K., King S.B., and Kim-Shapiro D.B. Urease enhances the formation of iron nitrosyl hemoglobin in the presence of hydroxyurea. Biochim. Biophys. Acta 1622 (2003) 109-116
9. Huang J., Hadimani S.B., Rupon J.W., Ballas S.K., Kim-Shapiro D.B., and King S.B. Iron nitrosyl hemoglobin formation from the reactions of hydroxyurea and hemoglobin. Biochemistry 41 (2002) 2466-2474
10. Huang J., Sommers E., Kim-Shapiro D.B., and King S.B. Horseradish peroxidase catalyzed nitric oxide formation from hydroxyurea. J. Am. Chem. Soc. 124 (2002) 3473-3480
11. Huang J., Kim-Shapiro D.B., and King S.B. Catalase-mediated nitric oxide formation from hydroxyurea. J. Med. Chem. 47 (2004) 3495-3501
12. Colvin M., and Bono Jr. V.H. The enzymatic reduction of hydroxyurea to urea by mouse liver. Cancer Res. 30 (1970) 1516-1519
13. 14C. J. Pharmacol. Exp. Ther. 150 (1965) 322-327
14. Jiang J., Jordan S.J., Barr D.P., Gunther M.R., Maeda H., and Mason R.P. In vivo production of nitric oxide in rats after administration of hydroxyurea. Mol. Pharmacol. 52 (1997) 1081-1086
15. Glover R.E., Ivy E.D., Orringer E.P., Maeda H., and Mason R.P. Detection of nitrosyl hemoglobin in venous blood in the treatment of sickle cell anemia with hydroxyurea. Mol. Pharmacol. 55 (1999) 1006-1010
16. Margoliash E., and Novogrodsky A. A study of the inhibition of catalase by 3-amino-1,2,4-triazole. Biochem. J. 68 (1957) 468-475
17. Peng S.X., Strojnowski M.J., Hu J.K., Smith B.J., Eichold T.H., Wehmeyer K.R., Pikul S., and Almstead N.G. Gas chromatographic mass spectrometric analysis of hydroxylamine for monitoring the metabolic hydrolysis of metalloprotease inhibitors in rat and human liver microsomes. J. Chromatogr. B 724 (1999) 181-187
18. Bernheim M.L.C. The enzymatic hydrolysis of certain hydroxamic acids. Arch. Biochem. Biophys. 107 (1964) 313-318
19. Wang P.G., Xian M., Tang X., Wu X., Wen Z., Cai T., and Janczuk A.J. Nitric oxide donors: chemical activities and biological applications. Chem. Rev. 102 (2002) 1091-1134
20. Lockamy V.L., Shields H., Kim-Shapiro D.B., and King S.B. Iron nitrosyl hemoglobin formation from the reaction of hydroxylamine and hemoglobin under physiological conditions. Biochim. Biophys. Acta 1674 (2004) 260-267
21. Miranda K. The chemistry of nitroxyl (HNO) and implications in biology. Coord. Chem. Rev. 249 (2005) 435-455
22. 2OH. J. Biol. Chem. 254 (1979) 8213-8222
23. Nagasawa H.T., DeMaster E.G., Redfern B., Shirota F.N., and Goon D.J.W. Evidence for nitroxyl in the catalase-mediated bioactivation of the alcohol deterrent agent cyanamide. J. Med. Chem. 33 (1990) 3120-3122
24. Shirota F.N., Goon D.J.W., DeMaster E.G., and Nagasawa H.T. Nitrosyl cyanide, a putative metabolic oxidation product of the alcohol-deterrent agent cyanamide. Biochem. Pharmacol. 52 (1996) 141-147
25. Cooper C.E. Nitric oxide and iron proteins. Biochim. Biophys. Acta 1411 (1999) 290-309
26. Reiter C.D., and Gladwin M.T. An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy. Curr. Opin. Hematol. 10 (2003) 99-107
27. Reiter C.D., Wang X., Tanus-Santos J.E., Hogg N., Cannon R.O., Schechter A.N., and Gladwin M.T. Cell-free hemoglobin limits nitric oxide bioavailability in sickle cell disease. Nat. Med. 8 (2002) 1383-1389
28. Aslan M., Ryan T.M., Adler B., Townes T.M., Parks D.A., Thompson J.A., Tousson A., Gladwin M.T., Patel R.P., Tarpey M.M., Batinic-Haberle I., White R.C., and Freeman B.A. Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proc. Natl. Acad. Sci. 98 (2001) 15215-15220
29. Cokic V.P., Smith R.D., Beleslin-Cokic B.B., Njoroge J.M., Miller J.L., Gladwin M.T., and Schechter A.N. Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase. J. Clin. Invest. 111 (2003) 231-239